Xiaoli Wei

3.1k total citations · 1 hit paper
82 papers, 2.4k citations indexed

About

Xiaoli Wei is a scholar working on Molecular Biology, Spectroscopy and Cellular and Molecular Neuroscience. According to data from OpenAlex, Xiaoli Wei has authored 82 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 14 papers in Spectroscopy and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Xiaoli Wei's work include Metabolomics and Mass Spectrometry Studies (19 papers), Analytical Chemistry and Chromatography (10 papers) and Neuroscience and Neuropharmacology Research (8 papers). Xiaoli Wei is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (19 papers), Analytical Chemistry and Chromatography (10 papers) and Neuroscience and Neuropharmacology Research (8 papers). Xiaoli Wei collaborates with scholars based in China, United States and Czechia. Xiaoli Wei's co-authors include Xiang Zhang, Craig J. McClain, Xinmin Yin, Seongho Kim, Xue Shi, Imhoi Koo, Yu Han, Yuxian Bai, Hong Sui and Yingnan Yang and has published in prestigious journals such as Journal of Biological Chemistry, Bioinformatics and PLoS ONE.

In The Last Decade

Xiaoli Wei

78 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer

2024 47 citations Yonger Chen, Jian Liang et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoli Wei China	30	1.5k	533	387	334	267	82	2.4k
Jiye Aa China	30	2.0k 1.3×	285 0.5×	286 0.7×	120 0.4×	365 1.4×	109	3.2k
Guisheng Zhou China	36	2.3k 1.6×	315 0.6×	180 0.5×	185 0.6×	136 0.5×	134	3.9k
Shuo Zhang China	31	2.0k 1.4×	1.2k 2.3×	202 0.5×	266 0.8×	118 0.4×	180	3.9k
Xin Tian China	31	1.7k 1.2×	656 1.2×	240 0.6×	144 0.4×	81 0.3×	189	3.3k
Xun Hu China	39	2.6k 1.7×	957 1.8×	297 0.8×	167 0.5×	99 0.4×	83	4.3k
Tracy A. Prime United Kingdom	32	2.4k 1.6×	153 0.3×	191 0.5×	238 0.7×	320 1.2×	38	3.6k
Duan‐Fang Liao China	30	2.2k 1.5×	734 1.4×	272 0.7×	188 0.6×	50 0.2×	120	3.9k
Josep J. Centelles Spain	29	1.4k 0.9×	493 0.9×	100 0.3×	165 0.5×	110 0.4×	88	2.7k
Kamelija Žarković Croatia	34	1.2k 0.8×	254 0.5×	295 0.8×	143 0.4×	48 0.2×	103	3.0k
Nina Kaludercic Italy	31	1.6k 1.1×	166 0.3×	243 0.6×	551 1.6×	63 0.2×	47	3.5k

Countries citing papers authored by Xiaoli Wei

Since Specialization

Citations

This map shows the geographic impact of Xiaoli Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Wei more than expected).

Fields of papers citing papers by Xiaoli Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Wei. The network helps show where Xiaoli Wei may publish in the future.

Co-authorship network of co-authors of Xiaoli Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Wei. A scholar is included among the top collaborators of Xiaoli Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Wei. Xiaoli Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shu, Hang, Xiaoli Wei, Jingjing Ji, et al.. (2025). Mannosylated neutrophil vesicles targeting macrophages alleviate liver inflammation by delivering CRISPR/Cas9 RNPs. Theranostics. 15(13). 6221–6235. 1 indexed citations

Wei, Xiaoli, et al.. (2025). Death Preparedness Scale for Advanced Cancer Patients: Instrument Development and Psychometric Properties. Psycho-Oncology. 34(4). e70149–e70149. 1 indexed citations

Xiang, Yang, Gen Li, Yuxuan Song, et al.. (2025). Aloe-emodin mitigates cisplatin-induced acute kidney injury by Nrf2-mediated ferroptosis regulation. Free Radical Biology and Medicine. 241. 104–116.

Wei, Xiaoli, Ye Chen, Wenguo Wang, et al.. (2025). Current Status and Influencing Factors of Death Preparedness in Advanced Cancer Patients Based on the PRECEDE ‐ PROCEED Model: A Cross‐Sectional Study. Journal of Advanced Nursing. 82(4). 3076–3090.

Wei, Xiaoli, Ru Zhang, Pu Chen, et al.. (2025). Mitochondria‐Targeted AIE Materials for Oxidative Stress‐Mediated Cancer Therapy and Beyond. Aggregate. 6(12).

Xu, Rong, Ashuai Du, Xinpei Deng, et al.. (2024). tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB. Journal of Experimental & Clinical Cancer Research. 43(1). 230–230. 29 indexed citations

Liu, Fangfang, Xiaoli Wei, Weineng Feng, et al.. (2024). Inhibitor of apoptosis proteins (IAP) inhibitor APG-1387 monotherapy or in combination with programmed cell death 1 (PD-1) inhibitor toripalimab in patients with advanced solid tumors: results from two phase I trials. ESMO Open. 9(8). 103651–103651. 1 indexed citations

Wei, Xiaoli, et al.. (2024). Inhibition of FSP1: A new strategy for the treatment of tumors (Review). Oncology Reports. 52(2). 10 indexed citations

Chen, Yonger, Jian Liang, Nan Lin, et al.. (2024). Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer. Molecular Cancer. 23(1). 196–196. 47 indexed citations breakdown →

10.

Chen, Lili, Xiangjian Zheng, Kun Zhang, et al.. (2023). Sustained-release nitrate combined with microbial fuel cell: A novel strategy for PAHs and odor removal from sediment. Journal of Hazardous Materials. 455. 131610–131610. 16 indexed citations

11.

Wei, Xiaoli, Biyun Shi, Imhoi Koo, et al.. (2017). Analysis of stable isotope assisted metabolomics data acquired by GC-MS. Analytica Chimica Acta. 980. 25–32. 16 indexed citations

12.

Wei, Xiaoli, Ming Li, Mingming Ma, et al.. (2016). Induction of apoptosis by FFJ-5, a novel naphthoquinone compound, occurs via downregulation of PKM2 in A549 and HepG2 cells. Oncology Letters. 13(2). 791–799. 3 indexed citations

13.

Shi, Xue, Xiaoli Wei, Xinmin Yin, et al.. (2015). Hepatic and Fecal Metabolomic Analysis of the Effects of Lactobacillus rhamnosus GG on Alcoholic Fatty Liver Disease in Mice. Journal of Proteome Research. 14(2). 1174–1182. 79 indexed citations

14.

Zhuo, Rengong, Peng Peng, Xiaoyan Liu, et al.. (2015). The isoforms generated by alternative translation initiation adopt similar conformation in the selectivity filter in TREK-2. Journal of Physiology and Biochemistry. 71(4). 601–610. 4 indexed citations

15.

Koo, Imhoi, Xiaoli Wei, Xue Shi, et al.. (2014). Constructing metabolic association networks using high-dimensional mass spectrometry data. Chemometrics and Intelligent Laboratory Systems. 138. 193–202. 1 indexed citations

16.

Du, Xiaoxue, Yanjing Li, Chunlong Wu, et al.. (2013). Initiation of apoptosis, cell cycle arrest and autophagy of esophageal cancer cells by dihydroartemisinin. Biomedicine & Pharmacotherapy. 67(5). 417–424. 53 indexed citations

17.

Wei, Xiaoli, Xue Shi, Seongho Kim, et al.. (2012). Data Preprocessing Method for Liquid Chromatography–Mass Spectrometry Based Metabolomics. Analytical Chemistry. 84(18). 7963–7971. 56 indexed citations

18.

Kim, Seongho, et al.. (2012). A method of finding optimal weight factors for compound identification in gas chromatography–mass spectrometry. Bioinformatics. 28(8). 1158–1163. 44 indexed citations

19.

Wei, Xiaoli, Wei Guo, Shuhong Wu, et al.. (2010). Oxidative stress in NSC-741909-induced apoptosis of cancer cells. Journal of Translational Medicine. 8(1). 37–37. 30 indexed citations

20.

Guo, Wei, Shuhong Wu, Li Wang, et al.. (2009). Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1 H -indole-3-carboxaldehyde (oncrasin-1). Molecular Cancer Therapeutics. 8(2). 441–448. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact